Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE2 | O96020 | 2/20 | 0.62 |
| ▸ | CDK4 | P11802 | 2/20 | 0.62 |
| ▸ | CCND1 | P24385 | 2/20 | 0.62 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.62 |
| ▸ | CDK2 | P24941 | 2/20 | 0.62 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30834690 | 0.93 | CAMK2D (0.61) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL30834686 | 0.89 | CCNE2 (0.71) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL30834689 | 0.89 | CDK2 (0.48) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL7529336 | 0.86 | CCNE2 (0.77) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL30834696 | 0.85 | CCNE2 (0.58) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL30834695 | 0.82 | CCNT1 (0.48) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL30834694 | 0.81 | PRKCA (0.64) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL8161998 | 0.79 | PIM1 (0.69) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL30834702 | 0.79 | PIM1 (0.69) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL28101197 | 0.79 | CCNE2 (0.53) | CCNE2CDK4CCND1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117886799-A | Protein degradation targeting chimeric compound for targeting degradation of GSK-3 beta and application thereof | 浙江工业大学 | 2024-04-16 | — | — | CN | disclosed |